Catherine C. Turkel

2019

In 2019, Catherine C. Turkel earned a total compensation of $597.7K as President at Tokai Pharmaceuticals, a 4% decrease compared to previous year.

Compensation breakdown

Option Awards$171,666
Salary$368,403
Stock Awards$53,478
Other$4,110
Total$597,657

Turkel received $368.4K in salary, accounting for 62% of the total pay in 2019.

Turkel also received $171.7K in option awards, $53.5K in stock awards and $4.1K in other compensation.

Rankings

In 2019, Catherine C. Turkel's compensation ranked 11,220th out of 13,971 executives tracked by ExecPay. In other words, Turkel earned more than 19.7% of executives.

ClassificationRankingPercentile
All
11,220
out of 13,971
20th
Division
Manufacturing
4,542
out of 5,701
20th
Major group
Chemicals And Allied Products
1,785
out of 2,200
19th
Industry group
Drugs
1,537
out of 1,886
19th
Industry
Pharmaceutical Preparations
1,137
out of 1,398
19th
Source: SEC filing on March 31, 2020.

Turkel's colleagues

We found two more compensation records of executives who worked with Catherine C. Turkel at Tokai Pharmaceuticals in 2019.

2019

Gregory Flesher

Tokai Pharmaceuticals

Chief Executive Officer

2019

Jon Kuwahara

Tokai Pharmaceuticals

Senior Vice President of Finance and Administration

News

You may also like